OTCMKTS:RNUGF - ReNeuron Group Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.35
+0.30 (1.20%)

This chart shows the closing price for RNUGF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ReNeuron Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RNUGF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RNUGF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for ReNeuron Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.35.

This chart shows the closing price for RNUGF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in ReNeuron Group. This rating has held steady since August 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/30/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/12/2019Maxim GroupReiterated RatingBuy$6.00
(Data available from 7/23/2016 forward)
ReNeuron Group logo
ReNeuron Group plc develops and sells cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate that is in Phase IIb clinical trial for stroke disability; and human retinal progenitor cell therapy that is in Phase I/IIa clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also developing CTX-derived exosomes, which are Nano-sized packages of information released by CTX cells. ReNeuron Group plc has a research agreement with U.S. biotechnology company in the discovery and development of novel gene silencing-based therapeutics. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
Read More

Today's Range

Now: $1.35
Low: $1.35
High: $1.35

50 Day Range

MA: $1.70
Low: $1.35
High: $1.96

52 Week Range

Now: $1.35
Low: $0.99
High: $1.96

Volume

N/A

Average Volume

121 shs

Market Capitalization

$42.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of ReNeuron Group?

The following Wall Street analysts have issued stock ratings on ReNeuron Group in the last year: Zacks Investment Research.
View the latest analyst ratings for RNUGF.

What is the current price target for ReNeuron Group?

0 Wall Street analysts have set twelve-month price targets for ReNeuron Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for ReNeuron Group in the next year.
View the latest price targets for RNUGF.

What is the current consensus analyst rating for ReNeuron Group?

ReNeuron Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RNUGF.

What other companies compete with ReNeuron Group?

How do I contact ReNeuron Group's investor relations team?

ReNeuron Group's physical mailing address is Pencoed Business Park Bridgend, Pencoed X0, CF35 5HY. The company's listed phone number is 44 20 3819 8400. The official website for ReNeuron Group is www.reneuron.com.